๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetic interpretation of the plasma levels of clonidine following transdermal delivery

โœ Scribed by Richard H. Guy; Jonathan Hadgraft

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
289 KB
Volume
74
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The pharmacokinetics and pharmacological
The pharmacokinetics and pharmacological effect of (S)-5-OH-DPAT following controlled delivery with transdermal iontophoresis
โœ Oliver W. Ackaert; Jeroen De Graan; Shanna Shi; Rob Vreeken; Oscar E. Della Pasq ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 820 KB

The pharmacokinetic (PK) and pharmacodynamic (PD) properties of the active (S)-enantiomer of the potent dopamine (DA) agonist 5-hydroxy-2-(N,N,-di-npropylamino)tetralin (5-OH-DPAT) were investigated in a novel anesthetized animal model. First, the relationship between current density, in vivo transp

Pharmacokinetics of 5-fluorouracil in th
Pharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticles
โœ Cory J. Hitzman; Lee W. Wattenberg; Timothy S. Wiedmann ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 215 KB

The inhalation delivery of 5-fluorouracil (5-FU) in lipid-coated nanoparticles (LNPs) to hamsters was evaluated to determine the feasibility for use in lung cancer chemotherapy. The inhaled dose, 30 mg LNPs/kg body weight (1.5 mg/kg 5-FU), was delivered over an 8-min interval. Fluorescein isothiocya

Pharmacokinetic modelling of the plasma
Pharmacokinetic modelling of the plasma concentration-time profile of the vitamin retinyl palmitate following intramuscular administration
โœ D. Hartmann; D. Gysel; U. C. Dubach; I. Forgo ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 514 KB

Seven healthy male volunteers (2 1-24 y) received by the ventro-gluteal route a single dose of 100 000 I.U. of the vitamin retinyl palmitate (RP) in a water-miscible preparation (w) and 5 weeks later the same dose in an oily solution (S). After administration of W median (range) peak plasma concentr

Pharmacokinetics of valproic acid and me
Pharmacokinetics of valproic acid and metabolites in mouse plasma and brain following constant-rate application of the drug and its unsaturated metabolite with an osmotic delivery system
โœ Heinz Nau; Rainer Zierer ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 603 KB

## Abstract Human therapeutic valproic acid (VPA) levels could be maintained in the mouse for a period of 1 week by constant rate application via subcutaneously implanted osmotic minipumps. Also, the concentrations of VPA metabolites observed in mouse plasma were similar to those seen in human plas